FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Wants iPLEDGE Web Site Solutions

FDA calls on isotretinoin manufacturers to propose a workable solution to issues with the iPLEDGE REMS Web site and telephone call center so treatment...

Human Drugs

Amcyte Pharma Marketing Illegal Covid Drug: FDA

FDA warns Kirkland, WA-based Amcyte Pharma it is illegally selling Nasitrol, an unapproved and misbranded drug, as a Covid-19 cure.

Human Drugs

Abbvie Gets Breakthrough Status on Lung Cancer Drug

FDA grants AbbVie a breakthrough therapy designation for telisotuzumab vedotin and its use in treating certain patients with advanced/metastatic epide...

Federal Register

Info Collection on Drug Compounding Facilities

Federal Register notice: FDA sends to OMB an information collection extension entitled Obtaining Information To Understand Challenges and Opportunitie...

Medical Devices

Fresenius Connect Infusion Cyber Alert

FDA says the Cybersecurity and Infrastructure Security Agency has identified vulnerabilities in the Fresenius Kabi Agilia Connect Infusion System.

Biologics

FDA Amends Pfizer Covid Vaccine EUA

FDA amends the Pfizer/BioNTech vaccine EUA to allow booster shots for those ages 12 to 15 and a shorter period between primary and booster shots.

Medical Devices

CDRH Hoping for Normal Review Times

CDRH officials say they are working toward normal review times in FY 2022.

Human Drugs

Covidien Class 1 Recall of Ventilator

FDA classifies as Class 1 a recall by Medtronics Covidien unit of its Puritan Bennett 980 Ventilator Series System due to a manufacturing assembly err...

Human Drugs

Court Orders End to Nano Silver Distribution

The New Jersey federal court enters a consent decree of permanent injunction against Natural Solutions Foundation and its principals to stop them from...

Human Drugs

FDA Approves Coherus BioSciences Yusimry

FDA approves Coherus BioSciences Yusimry, the seventh biosimilar form of AbbVies Humira approved by the agency.